KATHLEEN IANNITELLO: Open Payments
NPI 1518026467 · WAILUKU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 38 payments from 8 companies in 2025. Trend: 2023 $632 · 2024 $761 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $238 |
| ABBVIE INC. | 7 | $236 |
| Alkermes, Inc. | 8 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $203 |
| Neurocrine BioSciences, Inc. | 4 | $168 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, UZEDY, VIVITROL, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across HI — which companies pay providers there.
